The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Daisuke Ogiya, Jiye Liu, Hiroto Ohguchi, +7

Blood

Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways

Teru Hideshima, Daisuke Ogiya, Jiye Liu, +5

Leukemia

MedicineImmunologyPharmacologyCell DeathNk Cells +9

Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma

Hiroto Ohguchi, Paul M.C. Park, Tingjian Wang, +27

Blood Cancer Discovery

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Jiye Liu, Lijie Xing, Jiang Li, +19

Nature Communications

Hematological MalignancyCancer ImmunosurveillanceMedicineImmunologyImmunoediting +12

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment

Jiye Liu, Teru Hideshima, Lijie Xing, +17

Science Advances

Characteristics of CD5-Positive Splenic Marginal Zone Lymphoma with Leukemic Manifestation ; Clinical, Flow Cytometry, and Histopathological Findings of 11 Cases

Minoru Kojima, Eriko Sato, Kazuo Oshimi, +12

Journal of Clinical and Experimental Hematopathology

ImmunologyPathologyTumor BiologyHematological MalignancyOncology +18

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions

Sawako Shiraiwa, Yara Yukie Kikuti, Joaquim Carreras, +11

Journal of Clinical and Experimental Hematopathology

ImmunologyPathologyClassical Hodgkin LymphomaMethotrexate-associated Lymphoproliferative DisordersDermatology +16

Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies

Wataru Munakata, Kiyoshi Ando, Masahiro Yokoyama, +10

International Journal of Hematology

Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma

Shinsuke Iida, Daisuke Ogiya, Yasunobu Abe, +8

Cancer Science

Hematological MalignancyDose‐escalation StudyMedicineMalignant Blood DisorderHematology +13

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

Minoru Kojima, Daisuke Ogiya, Akifumi Ichiki, +12

Leukemia Research Reports